Approved PLCO Projects
Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| Defining the role of lipids and metabolic factors as risk factor for prostate cancer and prostate cancer aggressiveness. A PhD project | Adel Aref | The University of Adelaide Freemasons Foundation Centre for Men’s Health South Australian Health and Medical Research Institute | PLCO | Apr 20, 2017 | PLCO-272 |
| Melanoma GWAS | Maria Teresa Landi | NIH, NCI | PLCO | Apr 5, 2017 | PLCO-268 |
| Efficient estimation of AUC in nested case-control studies | Anil Chaturvedi | National Cancer institute | PLCO | Mar 31, 2017 | PLCO-269 |
| Germline genetics of metastasis: an across cancer analysis | Lisa Mirabello | National Cancer Institute, NIH | PLCO | Mar 29, 2017 | PLCO-267 |
| A case-crossover study of air pollution exposure and lung cancer related mortality in PLCO | Jason Wong | National Cancer Institute | PLCO | Mar 24, 2017 | PLCO-264 |
| The use of marginal structural model to determine the effect of non-steroidal anti-inflammatory drug use on the risk of prostate and ovarian cancer | Omonefe Omofuma | University of south Carolina | PLCO | Mar 17, 2017 | PLCO-265 |
| Molecular characterization of bladder tumors and studies of etiologic heterogeneity in the PLCO Trial | Stella Koutros | National Cancer Institute | PLCO | Mar 14, 2017 | 2016-0045 |
| Pancreatic Cancer Prediction using Machine Learning | Akshay Bodkhe | San Jose State University | PLCO | Mar 2, 2017 | PLCO-259 |
| PSA velocity and prostate cancer mortality in the PLCO Cancer Screening Trial | Kathryn Barry | University of Maryland School of Medicine | PLCO | Mar 1, 2017 | PLCO-261 |
| Genetic ancestry of African Americans who have been already genotyped in PLCO | Neal Freedman | NCI | PLCO | Mar 1, 2017 | PLCO-263 |
| Building a Common Data Model for Cancer Research | Guoqian Jiang | Mayo Clinic | PLCO | Feb 25, 2017 | PLCO-258 |
| BMI, weight change and the risk of colorectal cancer in the PLCO Cancer Screening Trial | Kathryn Barry | University of Maryland School of Medicine | PLCO | Feb 23, 2017 | PLCO-260 |
| Fertility, Ectopic Pregnancy, and Ovarian Cancer Risk | Suneeta Senapati | University of Pennsylvania Perelman School of Medicine | PLCO | Feb 23, 2017 | PLCO-262 |
| Distributed Automated Tuberculosis and Cancer Diagnosis | Jochen Nessel | Rai and Rohl Technologies, Inc. | PLCO | Feb 22, 2017 | PLCO-256 |
| Phase 3 validation of early detection biomarker panel for pancreatic cancer | Ann Oberg | Mayo Clinic | PLCO | Feb 2, 2017 | 2016-0041 |
| Compliance and Mortality | Paul Pinsky | NCI | PLCO | Feb 2, 2017 | PLCO-255 |
| Melanoma Data Analysis2 | Hovig Devejian | FSU | PLCO | Jan 24, 2017 | PLCO-253 |
| Request for access to the Ovarian Biomarkers data in order to correlate values with those obtained on our multiplex platform | Amy Skubitz | University of Minnesota | PLCO | Jan 20, 2017 | PLCO-254 |
| Absolute Risk Model Evaluation and Integration of Imaging Biomarkers for Early Detection and Risk Assessment of Cancer | Jae Lee | Moffitt Cancer Center | PLCO | Jan 12, 2017 | PLCO-248 |
| Examining Trends in Prostate Cancer Diagnosis, Treatment and Mortality | D. Duane Baldwin | Loma Linda University Health | PLCO | Jan 12, 2017 | PLCO-247 |